What are your thoughts of holding off on a confirming trial for the CV indications and focus a study on the diabetes benefits? Is there a savings in terms of timing to focus on the diabetes indication?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.